The Indian Patent Office published draft examination guidelines for biotechnology applications, with a pharmaceutical draft alongside. The biotechnology draft is the one with detail, and it leans on recent High Court rulings.
Category: India
Filing Divisional Application in India – Part 4
This is the fourth post in our 16-part series examining divisional practice in Argentina, Brazil, Canada, China, Europe, India, Indonesia, Malaysia, Mexico, Pakistan, Russia, Thailand, Saudi Arabia, Singapore, the United States, and Vietnam (in no particular order). Our first three …
Indian Government’s Proposal to Amend Patent Rules 2003 Will Impact Examination and Opposition Procedures
On December 4, 2018, India’s Department of Industrial Policy and Promotion, Ministry of Commerce and Industry published Draft Patent (Amendment) Rules, 2018 (Draft Rules) for comment. These Draft Rules seek to amend the Patent Rules, 2003. Key highlights of the …
USTR 2018 Special 301 Report – Priority Watch List Country – India
In April, the Office of the United States Trade Representative (USTR) released its 2018 Special 301 Report (the Report) identifying trading partners that do not adequately or effectively protect and enforce intellectual property (IP) rights or otherwise deny market access …
Read More "USTR 2018 Special 301 Report – Priority Watch List Country – India"
USTR 2018 Special 301 Report: Pharmaceutical and Medical Device Innovation and Market Access
Last month, the Office of the United States Trade Representative (USTR) released its 2018 Special 301 Report (the Report), identifying trading partners that do not adequately or effectively protect and enforce intellectual property (IP) rights or otherwise deny market access …